The Gluten Free Diet and Potential Alternative Therapies: The Road Ahead
|
|
- Gordon Park
- 5 years ago
- Views:
Transcription
1 The Gluten Free Diet and Potential Alternative Therapies: The Road Ahead Daniel Leffler MD, MS Associate Professor of Medicine Harvard Medical School HARVARD MEDICAL SCHOOL
2 Let Thy Food Be Thy Medicine Hippocrates, 400 AD Strict gluten free diet is the only accepted treatment for celiac disease The GFD is one of the more challenging treatments we assign patients GFD
3 Patient Satisfaction with the GFD is Low Controversial in the past Better scientific data and a more diverse celiac population general acceptance Sanders JGLD 2011
4 Treatment Burden is also Second Only to Hemodialysis Perceived Treatment Burden VAS* CD HTN GERD ESRD DM CHF IBD IBS *VAS: 0=Very Easy 100=Very Difficult Shah S, Leffler DA, AJG 2014
5 Spectrum of NRCD in Children and Adults Other 8% IBS 18% Gluten Exposure 35% RCD 11% SIBO 6% Eating Disorder 6% Disacchari dase Deficiency 9% Microsco pic Colitis 7% Leffler et al, CGH 2007; Veeraraghavan ACG 2015
6 Spectrum of NRCD in Children and Adults Other 8% IBS 18% Gluten Exposure 35% RCD 11% SIBO 6% Eating Disorder 6% Disacchari dase Deficiency 9% Microsco pic Colitis 7% Leffler et al, CGH 2007; Veeraraghavan ACG 2015
7 Histologic Recovery is Partial and Age Related Average Age of Celiac Diagnosis l/3 of people have a healthy intestine after 2 years 2/3 of people have a healthy intestine after 5 years Lebwohl et al. APT 2014, Rubio-Tapia AJG 2010, Leffler DA Gut 2012, Maki Gastro 2014
8 Three Main Therapeutic Classes Class Examples Intraluminal Therapies ALV003: oral protease combination of cysteine endoprotease B-soform 2 and prolyl endopeptidase Lazarotide Acetate: 8 polymer peptide and tight junction regulator KumaMax: Synthetic oral protease BL-7010: non-absorbable, co-polymer with high affinity for gliadins Immunosuppressants CCX282-B: Anti-CCR9 Blockade Hu-MiK-Beta-1: Humanized IL-15 specific antibody Immunotherapies Nexvax2: Vaccine COUR-NP-GLI: nanoparticle therapy
9 Intestinal Permeiabilty Theory of Mucosal Immune Homeostasis Chronic Inflammation-Allergy Normal/physiologically controlled permeability Minor barrier defect dietary/microbial Ag influx Increased permeability Massive dietary and microbial antigen influx Defensins Mucus Synthesis & Quality SIgA Mucosal Tolerance Homeostasis Anergy Regulatory DC s Macrophages Tregs IL-10/TGF-b Adapted from P. Brandtzaeg, Beneficial Microbes 2010 Inflammation - Allergy Innate or immunoregulatory defect Vicious cycle Proinflammatory Allergic cytokines Break of Tolerance Apoptosis resistant T cells Tissue damage Chronic inflammation Allergy
10 Total GSRS Score Change from Day 0 to Day 14 % Subjects with Gluten Toxicity Phase 2a Larazotide Acetate: Prevention of Signs & Symptoms of Gluten Exposure During Two Week Gluten Challenge Symptoms Score (GSRS) 60 Gluten-Related Adverse Events p = p = p = p = Disease Control Negative Control Active Treatment 0 Disease Control Negative Control Active Treatment No differences in primary endpoint of LA:MA Prevention of immunologic changes in PBMc (B cells) Daily diary: Reduction in frequency of bowel movements, abdominal discomfort & pain Safety comparable to placebo Daniel A Leffler, C P Kelly, H Z Abdallah, et al., A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease during Gluten Challenge, The American Journal of Gastroenterology doi: /ajg
11 Larazotide Phase 2c: 12 week trial in patients with persistent symptoms Leffler DA et al. Gastro 2015
12 ALV-003 (Alvine) ALV003 DEGRADES GLUTEN UP TO 96% IN HUMAN STOMACH % Epitope Remaining by ELISA 100% DESIGN Gluten: 1,000 mg Average 92% Dosage: 300 mg ALV003 of Disease Relevant Epitopes Eliminated Gluten Bread Crumbs in Complex Meal Stomach Content Analysis: 30 min 8.7% ± 0.2% 11% ± 0.2% 8.8% ± 0.1% 4.1% ± 0.1% Control Placebo NO ALV003 Subject #1 Subject #2 Subject #3 Treatment with ALV003 Subject #4
13 Phase 2a ALV-003: Prevention of Gluten Induced Mucosal Injury Exposure During 6 Week Gluten Challenge Lahdeaho ML, Kaukinen K, et al., Gastro 2014
14 Phase 2b ALV-003: 12 week trial in patients with persistent symptoms Vh:Cd Improvement Symptom Improvement Placebo 100mg 300mg 450mg 600mg 900mg Murray JA, et al., Gastro 2016
15 KumaMax Developed Using Computational Protein Design 1. Select Template Protease 2. Computational Design to Increase Activity 3. Test Designed Enzymes Kumamolisin from Alicyclobacillus sendaiensis Theoretical Mutation Intended to Increase Enzyme Activity Against Gliadin Substrate 4. Combine Promising Mutations Courtesy of Ingrid Swanson Pultz KumaMax Lead
16 KumaMax Efficiently Reduces Gluten In Foods and in Gastric Conditions EPB2/SCPEP KumaMax 10,000 ppm 84.8% 20 ppm >99.97% Courtesy of Ingrid Swanson Pultz
17 BL-7010 Non-absorbable, co-polymer with high affinity for gliadins
18 Nexvax (Nexpep) Peptide library: 18,117 12mers Dominant peptides 2,922 20mers 3 16AA Proteins Treatment shifts T cells from pro-inflammatory to tolerant response to gluten Induces tolerance in a celiac mouse model Phase 2a trials underway Nexvax administration symptoms mimicking oral gluten exposure
19 Courtesy of Tobias Frietag Nanoparticles
20 Courtesy of Tobias Frietag Nanoparticles
21 Development Requires Many Participants Phase Design n Duration Primary Outcome Preclinical T-cell activation, ex n/a n/a Prevention vivo duodenal biopsy or reversal of culture and/or celiac disease animal models activity Phase I Healthy control exposure, limited disease testing days Phase IIa Gluten challenge weeks Phase IIb Adjunctive treatment Phase III Adjunctive treatment? Safety/tolera bility Histology 12 weeks Symptoms (+/- histology) weeks Symptoms by validated PRO (+/- histology) Phase IV Open Label year Quality of life (+/- serology, histology) Secondary Outcomes Mechanism of action Early proof of concept Symptoms, serology Histology, serology Histology, serology Symptoms, serology, histology
22 Conclusions There is room for improvement in the way we manage celiac disease Novel therapeutics will significantly alter all aspects of celiac disease care, increasing diagnosis, encouraging monitoring and improving outcomes
23
24 the future of celiac disease. Leffler
25
Diet Isn t Working, We Need to Do Something Else
Diet Isn t Working, We Need to Do Something Else Ciarán P Kelly, MD Celiac Center Beth Israel Deaconess Medical Center & Celiac Program Harvard Medical School Boston Gluten Free Diet (GFD) Very good but
More informationLarazotide Acetate. Alessio Fasano, M.D. Mucosal Biology Research Center and Center for Celiac Research University of Maryland School of Medicine
Larazotide Acetate Alessio Fasano, M.D. Mucosal Biology Research Center and Center for Celiac Research University of Maryland School of Medicine Alternative/Integrative Approaches To The Gluten Free Diet
More informationCurrent Management of Celiac Disease and Identifying an Appropriate Patient Population(s) for Pharmacologic Therapies in Adult Patients
Current Management of Celiac Disease and Identifying an Appropriate Patient Population(s) for Pharmacologic Therapies in Adult Patients Joe Murray The Mayo Clinic 1 DISCLOSURES Relevant Financial Relationship(s)
More informationCeliac Disease: The Quintessential Autoimmune Disease Ivor D. Hill, MB, ChB, MD.
Celiac Disease: The Quintessential Autoimmune Disease Ivor D. Hill, MB, ChB, MD..... Celiac Disease Autoimmune Diseases What are they? How do you get them? Why does it matter? Celiac Disease Autoimmune
More informationCeliac Disease: The Future. Alessio Fasano, M.D. Mucosal Biology Research Center University of Maryland School of Medicine
Celiac Disease: The Future Alessio Fasano, M.D. Mucosal Biology Research Center University of Maryland School of Medicine Normal small bowel Celiac disease Gluten Gluten-free diet Treatment Only treatment
More informationCeliac disease: Beyond Glutenfree. AmerEl Sayed, MD LSGE- Annual Meeting 2014
Celiac disease: Beyond Glutenfree diet AmerEl Sayed, MD LSGE- Annual Meeting 2014 Pathogenesis Auto-immune disease, 1% western population 3 main pathways Host Genetic background HLA-DQ2 HLA-DQ8 Non-HLA
More informationActivation of Innate and not Adaptive Immune system in Gluten Sensitivity
Activation of Innate and not Adaptive Immune system in Gluten Sensitivity Update: Differential mucosal IL-17 expression in gluten sensitivity and the autoimmune enteropathy celiac disease A. Sapone, L.
More informationNew Insights on Gluten Sensitivity
New Insights on Gluten Sensitivity Sheila E. Crowe, MD, FRCPC, FACP, FACG, AGAF Department of Medicine University of California, San Diego Page 1 1 low fat diet low carb diet gluten free diet low fat diet
More informationPrimary Care Update January 26 & 27, 2017 Celiac Disease: Concepts & Conundrums
Primary Care Update January 26 & 27, 2017 Celiac Disease: Concepts & Conundrums Alia Hasham, MD Assistant Professor Division of Gastroenterology, Hepatology & Nutrition What is the Preferred Initial Test
More informationCeliac Disease Ce. Celiac Disease. Barry Z. Hirsch, M.D. Baystate Pediatric Gastroenterology and Nutrition. baystatehealth.org/bch
Celiac Disease Ce Celiac Disease Barry Z. Hirsch, M.D. Baystate Pediatric Gastroenterology and Nutrition baystatehealth.org/bch Autoimmune Disease Inappropriate inflammation 1 1/21/15 Celiac Disease Classic
More informationDisclosures GLUTEN RELATED DISORDERS CELIAC DISEASE UPDATE OR GLUTEN RELATED DISORDERS 6/9/2015
Disclosures CELIAC DISEASE UPDATE OR GLUTEN RELATED DISORDERS 2015 Scientific Advisory Board: Alvine Pharmaceuticals, Alba Therapeutics, ImmunsanT Peter HR Green MD Columbia University New York, NY GLUTEN
More informationIs It Celiac Disease or Gluten Sensitivity?
Is It Celiac Disease or Gluten Sensitivity? Mark T. DeMeo MD, FACG Rush University Med Center Case Study 35 y/o female Complains of diarrhea, bloating, arthralgias, and foggy mentation Cousin with celiac
More informationGluten Sensitivity Fact from Myth. Disclosures OBJECTIVES 18/09/2013. Justine Turner MD PhD University of Alberta. None Relevant
Gluten Sensitivity Fact from Myth Justine Turner MD PhD University of Alberta Disclosures None Relevant OBJECTIVES Understand the spectrum of gluten disorders Develop a diagnostic algorithm for gluten
More informationSee Policy CPT CODE section below for any prior authorization requirements
Effective Date: 1/1/2019 Section: LAB Policy No: 404 Medical Policy Committee Approved Date: 12/17; 12/18 1/1/19 Medical Officer Date APPLIES TO: All lines of business See Policy CPT CODE section below
More informationNo relevant financial relationships to disclose
CELIAC DISEASE Michael H. Piper, MD, FACP, FACG Gastroenterology Program Director Chief of Gastroenterology Providence-Providence Park Hospitals/St. John Macomb Hospital No relevant financial relationships
More informationDiagnostic Testing Algorithms for Celiac Disease
Diagnostic Testing Algorithms for Celiac Disease HOT TOPIC / 2018 Presenter: Melissa R. Snyder, Ph.D. Co-Director, Antibody Immunology Laboratory Department of Laboratory Medicine and Pathology, Mayo Clinic
More informationVaccination for Celiac Disease: utopia or concrete hope for Celiac Disease recovery
Vaccination for Celiac Disease: utopia or concrete hope for Celiac Disease recovery January 31, 2012 ImmusanT, Inc One Broadway, 14th Floor Cambridge, MA 02142 Key Points Objective: Treatment of celiac
More informationDiseases of the gastrointestinal system Dr H Awad Lecture 5: diseases of the small intestine
Diseases of the gastrointestinal system 2018 Dr H Awad Lecture 5: diseases of the small intestine Small intestinal villi Small intestinal villi -Villi are tall, finger like mucosal projections, found
More informationTherapeutical implication of regulatory cells and cytokines in celiac disease
Institute of Food Sciences, CNR Avellino, Italy Therapeutical implication of regulatory cells and cytokines in celiac disease Carmen Gianfrani Mastering the coeliac condition: from medicine to social sciences
More informationSlides and Resources.
Update on Celiac Disease Douglas L. Seidner, MD, AGAF, FACG Director, Center for Human Nutrition Vanderbilt University As revised/retold by Edward Saltzman, MD Tufts University None Disclosures This ppt
More informationCeliac Disease and Non Celiac Gluten Sensitivity. John R Cangemi, MD Mayo Clinic Florida
Celiac Disease and Non Celiac Gluten Sensitivity John R Cangemi, MD Mayo Clinic Florida DISCLOSURE Commercial Interest None Off Label Usage None Learning Objectives Review the clinical presentation of
More informationHOW LONG UNTIL TRULY GLUTEN-FREE?
HOW LONG UNTIL TRULY GLUTEN-FREE? A TIMELINE FOR SELF-MANAGEMENT SKILL ACQUISITION IN ADULTS WITH CELIAC DISEASE Emma M. Clerx National Celiac Association Fall Meeting 10/29/2017 A LITTLE BIT ABOUT ME
More informationImmune mediated enteropathies. Aurora Tatu Bern 26/07/2017
Immune mediated enteropathies Aurora Tatu Bern 26/07/2017 Definition/classification Systemic disease, mediated by antibodies, caracterised by histological changes of the small bowel Coeliac and noncoeliac
More informationREFERENCE CODE GDHC036POA PUBLICAT ION DATE NOVEMBER 2014 CELIAC DISEASE - OPPORTUNITY ANALYSIS AND FORECAST TO 2023
REFERENCE CODE GDHC036POA PUBLICAT ION DATE NOVEMBER 2014 CELIAC DISEASE - Executive Summary Table below presents the key metrics for celiac disease in the six major pharmaceutical markets (6MM) (US, France,
More informationNovember Laboratory Testing for Celiac Disease. Inflammation in Celiac Disease
November 2011 Gary Copland, MD Chair, Department of Pathology, Unity Hospital Laboratory Medical Director, AMC Crossroads Chaska and AMC Crossroads Dean Lakes Laboratory Testing for Celiac Disease Celiac
More informationChallenges in Celiac Disease. Adam Stein, MD Director of Nutrition Support Northwestern University Feinberg School of Medicine
Challenges in Celiac Disease Adam Stein, MD Director of Nutrition Support Northwestern University Feinberg School of Medicine Disclosures None Overview Celiac disease Cases Celiac disease Inappropriate
More informationBaboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease
Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease Debby Kryszak 1, Henry McGill 2, Michelle Leland 2,, Alessio Fasano 1 1. Center for Celiac Research,
More informationDDW WRAP-UP 2012 CELIAC DISEASE. Anju Sidhu MD University of Louisville Gastroenterology, Hepatology and Nutrition June 21, 2012
DDW WRAP-UP 2012 CELIAC DISEASE Anju Sidhu MD University of Louisville Gastroenterology, Hepatology and Nutrition June 21, 2012 OVERVIEW Definition Susceptibility The Changing Clinical Presentation Medical
More informationGluten-Free China Gastro Q&A
Gluten-Free China Gastro Q&A Akiko Natalie Tomonari MD akiko.tomonari@parkway.cn Gastroenterology Specialist ParkwayHealth Introduction (of myself) Born in Japan, Raised in Maryland, USA Graduated from
More informationManagement Celiac Disease Yesterday, Today, Tomorrow. Chris Mulder 20th of September 2016 Brisbane
Management Celiac Disease Yesterday, Today, Tomorrow Chris Mulder 20th of September 2016 Brisbane Sidney Haas Pediatrician New York City 1924 1870-1964 Albumin Milk - Dates Pot cheese - Oranges 4 8 Bananas
More informationDEAMIDATED GLIADIN PEPTIDES IN COELIAC DISEASE DIAGNOSTICS
DEAMIDATED GLIADIN PEPTIDES IN COELIAC DISEASE DIAGNOSTICS Z. Vanickova 1, P. Kocna 1, K. Topinkova 1, M. Dvorak 2 1 Institute of Clinical Biochemistry & Laboratory Diagnostics; 2 4th Medical Department,
More informationSpectrum of Gluten Disorders
Food Intolerance:Celiac Disease and Gluten Sensitivity-A Guide for Healthy Lifestyles Ellen Karlin 2018 Spectrum of Gluten Disorders Wheat allergy - prevalence 3-8 % (up to 3 years old) Non-celiac gluten
More informationCeliac Disease Myths. Objectives. We Now Know. Classical Celiac Disease. A Clinical Update in Celiac Disease
4:15 5:00pm Presenter Disclosure Information A Clinical Update in Celiac Disease SPEAKER Benjamin Lebwohl, MD, MS The following relationships exist related to this presentation: Benjamin Lebwohl, MD, MS
More informationGluten Free and Still Symptomatic
How many celiac patients are affected? Gluten Free and Still Symptomatic 6.2% of all celiac patients have continuing diarrhea after 2 years on a gluten free diet 18% will develop constipation in this time
More informationUniversity of Tampere, Faculty of Medicine and Life Sciences Arvo building, Arvo Ylpön katu 34, Tampere, Finland
TAMPERE CELIAC DISEASE SYMPOSIUM 2018 Serology and Biomarkers September 13-15, 2018 University of Tampere, Faculty of Medicine and Life Sciences Arvo building, Arvo Ylpön katu 34, 33520 Tampere, Finland
More informationProspettive di terapia
Istituto di Scienze dell Alimentazione, CNR Avellino Prospettive di terapia Carmen Gianfrani Corso di Aggiornamento La Celiachia nel terzo millennio: dalla diagnosi alla terapia Caserta 5 Maggio 2012 Both
More informationUniversity of Tampere, Faculty of Medicine and Life Sciences Arvo Building, Arvo Ylpön katu 34, Tampere, Finland
TAMPERE CELIAC DISEASE SYMPOSIUM 2018 Serology and Biomarkers September 13-15, 2018 University of Tampere, Faculty of Medicine and Life Sciences Arvo Building, Arvo Ylpön katu 34, 33520 Tampere, Finland
More informationThe immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet
Semin Immunopathol (2012) 34:581 600 DOI 10.1007/s00281-012-0318-8 REVIEW ARTICLE The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet Christopher S. McAllister
More informationDiagnosis Diagnostic principles Confirm diagnosis before treating
Diagnosis 1 1 Diagnosis Diagnostic principles Confirm diagnosis before treating Diagnosis of Celiac Disease mandates a strict gluten-free diet for life following the diet is not easy QOL implications Failure
More informationAm I a Silly Yak? Laura Zakowski, MD. No financial disclosures
Am I a Silly Yak? Laura Zakowski, MD No financial disclosures Patient NP 21 year old male with chronic headaches for 6 years extensively evaluated and treated Acupuncturist suggests testing for celiac
More informationCeliac & Gluten Sensitivity; serum
TEST NAME: Celiac & Gluten Sensitivity (Serum) Celiac & Gluten Sensitivity; serum ANTIBODIES REFERENCE RESULT/UNIT INTERVAL NEG WEAK POS POSITIVE Tissue Transglutaminase (ttg) IgA 1420 U < 20.0 Tissue
More informationCeliac Disease. Etiology. Food Intolerance:Celiac Disease and Gluten Sensitivity-A Guide for Healthy Lifestyles
Food Intolerance:Celiac Disease and Gluten Sensitivity-A Guide for Healthy Lifestyles Ellen Karlin 2017 Celiac Disease World s most common genetic food disorder Rising prevalence - over past 5 decades,
More informationSunanda Kane, MD, MSPH, FACG, FACP, AGAF Associate Professor of Medicine Mayo Clinic
Serum Markers: What, Who, When and Why? Sunanda Kane, MD, MSPH, FACG, FACP, AGAF Associate Professor of Medicine Mayo Clinic Crohn s Disease: Microbial Antibodies ASCA Anti-I2 Anti-OmpC Bir1 Flagellin
More informationLiving with Coeliac Disease Information & Support is key
Living with Coeliac Disease Information & Support is key Mary Twohig Chairperson Coeliac Society of Ireland What is Coeliac Disease? LIVING WITH COELIAC DISEASE Fact Not Fad Auto immune disease - the body
More informationOrganic - functional. Opposing views. Simple investigation of GI disorders. The dollar questions. Immune homeostasis of mucosa
Mucosal immunology and immunopathology (IBD, CD & NCGS) Ass. Prof. Knut E. A. Lundin, MD, PhD Endoscopy Unit, Dept of Transplantation medicine Centre for Immune Regulation www.med.uio.no/cir/english Oslo
More informationNew Gluten World S.r.l. Carmen Lamacchia
EURO GLOBAL SUMMIT AND EXPO ON FOOD AND BEVERAGES AN INNOVATIVE METHOD FOR THE DETOXIFICATION OF GLUTEN PROTEINS FROM GRAINS OF CEREALS New Gluten World S.r.l. Carmen Lamacchia Lead inventor and founder
More informationHealth Canada s Position on Gluten-Free Claims
June 2012 Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch 0 Table of Contents Background... 2 Regulatory Requirements for Gluten-Free Foods... 2 Recent advances in the knowledge
More informationWHY IS THERE CONTROVERSY ABOUT FOOD ALLERGY AND ECZEMA. Food Allergies and Eczema: Facts and Fallacies
Food Allergies and Eczema: Facts and Fallacies Lawrence F. Eichenfield,, M.D. Professor of Clinical Pediatrics and Medicine (Dermatology) University of California, San Diego Rady Children s s Hospital,
More informationPeter HR Green MD. Columbia University New York, NY
CELIAC DISEASE, 2008 Peter HR Green MD Celiac Disease Center Columbia University New York, NY pg11@columbia.edu DIAGNOSIS OF CELIAC DISEASE Presence of consistent pathology and response to a gluten-free
More informationWhat s New in Celiac Disease. Brooks D. Cash, MD, FACG Professor of Medicine Division of Gastroenterology University of South Alabama.
What s New in Celiac Disease Brooks D. Cash, MD, FACG Professor of Medicine Division of Gastroenterology University of South Alabama Disclosures No relevant disclosures Copyright 2015 American College
More informationCeliac Disease. Gluten-Sensitive Enteropathy Celiac Sprue Non-tropical Sprue
Celiac Disease Gluten-Sensitive Enteropathy Celiac Sprue Non-tropical Sprue Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationFOOD ALLERGY AND ANAPHYLAXIS PROGRAM
FOOD ALLERGY AND ANAPHYLAXIS PROGRAM Phoebe and Paul (above), both living with nut allergies, are among the many Canadian children that the SickKids Food Allergy and Anaphylaxis Program will benefit. Parents,
More informationEAT ACCORDING TO YOUR GENES. NGx-Gluten TM. Personalized Nutrition Report
EAT ACCORDING TO YOUR GENES NGx-Gluten TM Personalized Nutrition Report Introduction Hello Caroline: Nutrigenomix is pleased to provide you with your NGx-Gluten TM Personalized Nutrition Report based on
More informationFood Allergies Among Children -
Food Allergies Among Children - Growth, Treatment, Prevention and a Challenge for the Food Industry Steve L. Taylor, Ph.D. Food Allergy Research & Resource Program University of Nebraska Food Navigator
More informationBIOPSY AVOIDANCE IN CHILDREN: THE EVIDENCE
BIOPSY AVOIDANCE IN CHILDREN: THE EVIDENCE Steffen Husby Hans Christian Andersen Children s Hospital Odense University Hospital DK-5000 Odense C, Denmark Agenda Background Algorithm Symptoms HLA Antibodies
More informationCeliac Disease: You ve Come A Long Way Baby!
Celiac Disease: You ve Come A Long Way Baby! Celiac Disease (CD): How You ve Changed Increasing numbers of people have celiac disease Changing ways in which celiac disease presents A better understanding
More informationSequoia Education Systems, Inc. 1
Functional Medicine University s Functional Diagnostic Medicine Program Module 3 * FDMT 527C The Elimination Diet & The Modified Elimination Diet Wayne L. Sodano, D.C., D.A.B.C.I. & Ron Grisanti, D.C.,
More informationFunctional Medicine Is the application of alternative holistic measures to show people how to reverse thyroid conditions, endocrine issues, hormone
Functional Medicine Is the application of alternative holistic measures to show people how to reverse thyroid conditions, endocrine issues, hormone issues, fibromyalgia, autoimmunity diseases and the like.
More informationOur simple 3 step process to help you discover if gluten could be a problem for you!
Does gluten REALLY matter? Our simple 3 step process to help you discover if gluten could be a problem for you! A Publication of WMSOA Table of Contents Chapter 1: Why does gluten even matter Chapter 2:
More informationMeredythe A. McNally, M.D. Gastroenterology Associates of Cleveland Beachwood, OH
Meredythe A. McNally, M.D. Gastroenterology Associates of Cleveland Beachwood, OH Case in point 42 year old woman with bloating, gas, intermittent diarrhea alternating with constipation, told she has IBS
More informationCeliac disease Crohn s disease Ulcerative colitis Pseudomembranous colitis
2017 / 2018 2nd semester/3rd practice Celiac disease Crohn s disease Ulcerative colitis Pseudomembranous colitis Semmelweis University 2nd Department of Pathology CELIAC DISEASE = Gluten-sensitive enteropathy
More informationFollow-up Management of Patients with Celiac Disease: Resource for Health Professionals
Follow-up Management of Patients with Celiac Disease: Resource for Health Professionals Jocelyn Silvester, MD PhD FRCPC April 27, 2017 Research grants Disclosures Canadian Institutes of Health Research
More informationFrontiers in Food Allergy and Allergen Risk Assessment and Management. 19 April 2018, Madrid
Frontiers in Food Allergy and Allergen Risk Assessment and Management 19 April 2018, Madrid Food allergy is becoming one of the serious problems of China's food safety and public health emergency. 7 Number
More informationThe Clinical Response to Gluten Challenge: A Review of the Literature
Nutrients 2013, 5, 4614-4641; doi:.3390/nu5114614 Review OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients The Clinical Response to Gluten Challenge: A Review of the Literature Maaike
More informationCELIAC DISEASE - GENERAL AND LABORATORY ASPECTS Prof. Xavier Bossuyt, Ph.D. Laboratory Medicine, Immunology, University Hospital Leuven, Belgium
CELIAC DISEASE - GENERAL AND LABORATORY ASPECTS Prof. Xavier Bossuyt, Ph.D. Laboratory Medicine, Immunology, University Hospital Leuven, Belgium 5.1 Introduction Celiac disease is a chronic immune-mediated
More informationHistory of Food Allergies
Grand Valley State University From the SelectedWorks of Jody L Vogelzang PhD, RDN, FAND, CHES Spring 2013 History of Food Allergies Jody L Vogelzang, PhD, RDN, FAND, CHES, Grand Valley State University
More informationAccording to a post-hoc analysis, 62.6% of patients receiving Viaskin Peanut showed an increase in their eliciting dose at 12 months of treatment
Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American
More informationUnderstanding Food Intolerance and Food Allergy
Understanding Food Intolerance and Food Allergy There are several different types of sensitivities or adverse reactions to foods. One type is known as a food intolerance ; an example is lactose intolerance.
More informationDiagnostic and Management Dilemmas in Celiac Disease
Issues for Consideration Diagnostic and Management Dilemmas in Celiac Disease Approaches for diagnosing celiac disease Role of genetic testing How to evaluate someone already on a GFD What to do with non-responsive
More informationGUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE
GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE These are the lactose intolerance guidelines and it is recommended that they are used in conjunction with the Cow s Milk Allergy guidance.
More informationViaskin Peanut Highlights. Press Release Montrouge, France, March 5, 2017
Press Release Montrouge, France, March 5, 2017 Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut
More informationGI Allergy and Tolerance. Jon A. Vanderhoof, M.D. Division of Gastroenterology/Nutrition Boston Children s Hospital Harvard Medical School
GI Allergy and Tolerance Jon A. Vanderhoof, M.D. Division of Gastroenterology/Nutrition Boston Children s Hospital Harvard Medical School Disclosure Medical Advisor- Mead Johnson Nutrition Food Allergy
More informationprevalence 181 Atopy patch test, see Patch test
Subject Index AD, see Atopic dermatitis Adrenaline, anaphylaxis management 99 101, 194, 195 Adverse food reaction definition 4 nonallergic reactions 6, 9 Allergen Nomenclature database 20, 21 Allergen
More informationEsperanza Garcia-Alvarez MD Medical Director Pediatric Celiac Center at Advocate Children s Hospital
Esperanza Garcia-Alvarez MD Medical Director Pediatric Celiac Center at Advocate Children s Hospital Nothing to disclose Objectives Better understanding pathogenesis celiac disease Better understanding
More informationFPIES ANOTHER DISEASE ABOUT WHICH YOU SHOULD KNOW OBJECTIVES FPIES FPIES 11/10/2016. What is that? Robert P. Dillard, M.D.
ANOTHER DISEASE ABOUT WHICH YOU SHOULD KNOW What is that? Robert P. Dillard, M.D. Food Protein Induced Enterocolitis Syndrome. OBJECTIVES 1: Awareness of this syndrome 2: Characteristics 3: Diagnosis 4:
More informationGluten and the skin: Celiac disease and gluten sensitivity for the dermatologist
2/10/18 Gluten and the skin: Celiac disease and gluten sensitivity for the dermatologist 76th Annual American Academy of Dermatology Meeting February 16th, 2017 Matthew Goldberg, MD Assistant Professor,
More information588-Complete Dietary Antigen Testing
REPORT-1857 9 Dunwoody Park, Suite 121 Dunwoody, GA 3338 P: 678-736-6374 F: 77-674-171 Email: info@dunwoodylabs.com www.dunwoodylabs.com PATIENT INFO NAME: SAMPE PATIENT REQUISITION ID: 1857 SAMPE ID:
More informationEvidence Based Guideline
Evidence Based Guideline Serologic Diagnosis of Celiac Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: serologic_diagnosis_of_celiac_disease 4/2012 Description of Procedure
More informationPain = allergy surely true?
Pain = allergy surely true? Dr Warren Hyer Consultant Paediatrician Consultant Paediatric Gastroenterologist Educational objectives Screamers silent reflux is this an internet diagnosis PPI s for abdominal
More informationNon-dietary methods in the treatment of celiac disease
Review paper Anna Szaflarska-Popławska Department of Paediatric Endoscopy and Gastrointestinal Function Testing, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun,
More informationGluten sensitivity in Multiple Sclerosis Experimental myth or clinical truth?
Gluten sensitivity in Multiple Sclerosis Experimental myth or clinical truth? Annals of the New York Academy of Sciences, Vol 1173, Issue 1, page 44, Issue published online 3 Sep 2009. Dana Ben-Ami Shor,
More information2013 NASPGHAN FOUNDATION
2 Alessio Fasano, MD Visiting Professor of Pediatrics Harvard Medical School Chief of Pediatric Gastroenterology and Nutrition MassGeneral Hospital for Children Director, Center for Celiac Research Director,
More informationReview Article Novel Therapeutic/Integrative Approaches for Celiac Disease and Dermatitis Herpetiformis
Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2012, Article ID 959061, 7 pages doi:10.1155/2012/959061 Review Article Novel Therapeutic/Integrative Approaches for Celiac Disease
More informationCeliac Disease 1/13/2016. Objectives. Question 1. Understand the plethora of conditions or symptoms that require testing for Celiac Disease (CD)
Celiac Disease MONTE E. TROUTMAN, DO, FACOI JANUARY 6, 2016 Objectives Understand the plethora of conditions or symptoms that require testing for Celiac Disease (CD) Develop a knowledge of testing needed
More informationCeliac Disease and Gluten Sensitivity: New Tests and Approaches
Celiac Disease and Gluten Sensitivity: New Tests and Approaches Joseph A Murray Mayo Clinic, Rochester, MN DISCLOSURE Relevant Financial Relationship(s) Alba Therapeutics: grant support Alvine Inc: Advisory
More informationCONTEMPORARY CONCEPT ON BASIC APSECTS OF GLUTEN-SENSITIVE ENTEROPATHY IN ELDERLY PATIENTS
VIII, 2014, 1 33. 1,. 2,. - 1,. 1. 3 1,., 2,., 3, CONTEMPORARY CONCEPT ON BASIC APSECTS OF GLUTEN-SENSITIVE ENTEROPATHY IN ELDERLY PATIENTS Ts. Velikova 1, Z. Spassova 2,. Ivanova-Todorova 1, D. Kyurkchiev
More informationThe miraculous power of Bulgarian yogurt. Created by LB BULGARICUM
The miraculous power of Bulgarian yogurt HISTORY REMARKS Its secret is hidden in its micro-flora and the specific combination of strains from two species - Lactobacillus bulgaricus and Streptococcus thermophilus
More informationCeliac disease is a unique disorder that is both a food
GASTROENTEROLOGY 2006;131:1981 2002 American Gastroenterological Association () Institute Technical Review on the Diagnosis and Management of Celiac Disease This technical review addresses the state of
More informationThe first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.
Bio-Rad Laboratories BIOPLEX 2200 SYSTEM BioPlex 2200 Celiac IgA and IgG Kits The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing. The
More informationBeth Strong, RN, FNP-C The Jaffe Food Allergy Institute Mount Sinai School of Medicine New York 2/23/13
Beth Strong, RN, FNP-C The Jaffe Food Allergy Institute Mount Sinai School of Medicine New York 2/23/13 I do not have any financial disclosure to report Why Challenge? To confirm that the suspected food
More informationGUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE AND PRESCRIPTION OF LOW LACTOSE INFANT FORMULA.
GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE AND PRESCRIPTION OF LOW LACTOSE INFANT FORMULA. These are the lactose intolerance guidelines and it is recommended that they are used in
More informationCarlo Catassi; Alessio Fasano Curr Opin Gastroenterol. 2008;24(6): Lippincott Williams & Wilkins Posted 12/05/2008
Celiac Disease Carlo Catassi; Alessio Fasano Curr Opin Gastroenterol. 2008;24(6):687-691. 2008 Lippincott Williams & Wilkins Posted 12/05/2008 Abstract and Introduction Abstract Purpose of Review: Recent
More informationThe first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.
Bio-Rad Laboratories bioplex 2200 SYSTEM BioPlex 2200 Celiac IgA and IgG Kits * The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.
More informationFood Allergy A buffet of truths and myths
Food Allergy A buffet of truths and myths Toronto Anaphylaxis Education Group Adelle R. Atkinson M.D. FRCPC Associate Professor of Paediatrics University of Toronto Clinical Immunologist Division of Immunology
More informationCeliac Disease For Dummies By Sheila Crowe, Ian Blumer READ ONLINE
Celiac Disease For Dummies By Sheila Crowe, Ian Blumer READ ONLINE Celiac disease definition, a hereditary digestive disorder involving intolerance to gluten, usually occurring in young children, characterized
More informationName of Policy: Human Leukocyte Antigen (HLA) Testing for Celiac Disease
Name of Policy: Human Leukocyte Antigen (HLA) Testing for Celiac Disease Policy #: 545 Latest Review Date: June 2015 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule, benefits
More informationGluten-Free Living: Helping People to Eat Safely, Healthfully and Happily
Gluten-Free Living: Helping People to Eat Safely, Healthfully and Happily Rachel Begun, MS, RDN www.rachelbegun.com @RachelBegunRD What is Gluten? What is Gluten? Gluten is the collective term for a group
More informationOral food immunotherapy/desensitization
Oral Immunotherapy and Anti-IgE Antibody- Adjunctive Treatment for Food Allergy: Omalizumab facilitates oral desensitization in high-risk peanut allergy patients Dale T. Umetsu, MD, PhD The Prince Turki
More informationNASSCD Guide to Celiac Sessions at DDW 2018 June 2 5, 2018 Washington, DC
R NASSCD Guide to Celiac Sessions at DDW 2018 June 2 5, 2018 Washington, DC Date / Track June 2 BASIC SCIENCE Rm145 B, 3:00pm-3:30pm Problems Designing Trials in Celiac Diseases and Potential Remedies
More informationReview Article Celiac Disease and Gluten-Free Oats: A Canadian Position Based on a Literature Review
Canadian Journal of Gastroenterology and Hepatology Volume 2016, Article ID 1870305, 10 pages http://dx.doi.org/10.1155/2016/1870305 Review Article Celiac Disease and Gluten-Free Oats: A Canadian Position
More information